1.
Tamrakar R, Tamrakar D. Virologic Response Following a Switch to Dolutegravir-based Regimen in People Living with HIV/AIDS at a Tertiary Care Center in Nepal. Kathmandu Univ. Med. J. [Internet]. 2022 Dec. 31 [cited 2024 Jul. 24];20(4):438-42. Available from: https://nepjol.info/index.php/KUMJ/article/view/54081